Budhaditya Mukherjee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Budhaditya Mukherjee has a total of 167 co-authors. Here are the top co-authors by number of shared publications:
Supratim Pradhan
School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, West Bengal-721302, India
8 shared publicationsDebolina Manna
6 shared publicationsRupkatha Mukhopadhyay
Department of Infectious Diseases and Immunology, Council of Scientific and Industrial Research, Indian Institute of Chemical Biology, Kolkata 700032, India
6 shared publicationsSandip Mukherjee
Department of Infectious Disease and Immunology, Council of Scientific & Industrial Research (CSIR)-Indian Institute of Chemical Biology
6 shared publicationsShatarupa Bhattacharya
School of Medical Science and Technology, IIT Kharagpur, India
6 shared publicationsShyam Sundar
School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, India
6 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Wiley in MedComm – Oncology
- Vol. 5 (3)
Oxidative and Antioxidant Systems in Ferroptosis of Cancer: Mechanisms, Regulations, and Therapeutic Targeting
Ferroptosis is a redox‐governed, non‐apoptotic cell death program driven by iron‐dependent lipid peroxidation. Its execution depends on the balance between reactive oxygen species (ROS) generation and hierarchical antioxidant defenses. Despite extensive biochemical mapping, an integrated framework delineating how diverse redox defense systems converge to dictate ferroptotic sensitivity across tumor contexts remains lacking. This review delineates the hallmarks and molecular mechanisms of ferroptosis, examining how ROS sources within mitochondrial, the endoplasmic reticulum, membranes, and the cytoplasm drive lipid peroxidation. The antioxidant landscape is systematically classified into three functional tiers: (1) the primary canonical glutathione‐GPX4 axis, (2) secondary non‐canonical and radical‐trapping systems including FSP1‐CoQ10, GCH1‐BH4, peroxiredoxins, and vitamin K, and (3) tertiary metabolic support and detoxification systems encompassing thioredoxin, AKR1C enzymes, SOD‐catalase, and NADPH regeneration. The regulation of these defenses by master signaling hubs including NRF2, AMPK‐mTOR, ATF4, STAT3, Wnt/beta‐catenin, p53, and ncRNAs is evaluated, alongside oncogenic metabolic adaptations creating exploitable vulnerabilities in high‐plasticity states including epithelial to mesenchymal transition, cancer stem cells, hypoxic, matrix‐detached, and chemoresistant cells. Tumor microenvironment crosstalk among cancer‐associated fibroblasts and immune effectors, including CD8 + T cells, natural killer cells, macrophages, and myeloid‐derived suppressor cells, and therapeutic strategies spanning pharmacological and nanomaterial‐based approaches are further examined. Collectively, this synthesis furnishes a mechanistic framework for precision exploitation of ferroptosis across oncological contexts.
- 1 July 2026
- Published by Wiley in MedComm – Oncology
- Vol. 5 (3)
Open AccessOxidative and Antioxidant Systems in Ferroptosis of Cancer: Mechanisms, Regulations, and Therapeutic Targeting
Ferroptosis is a redox‐governed, non‐apoptotic cell death program driven by iron‐dependent lipid peroxidation. Its execution depends on the balance between reactive oxygen species (ROS) generation and hierarchical antioxidant defenses. Despite extensive biochemical mapping, an integrated framework delineating how diverse redox defense systems converge to dictate ferroptotic sensitivity across tumor contexts remains lacking. This review delineates the hallmarks and molecular mechanisms of ferroptosis, examining how ROS sources within mitochondrial, the endoplasmic reticulum, membranes, and the cytoplasm drive lipid peroxidation. The antioxidant landscape is systematically classified into three functional tiers: (1) the primary canonical glutathione‐GPX4 axis, (2) secondary non‐canonical and radical‐trapping systems including FSP1‐CoQ10, GCH1‐BH4, peroxiredoxins, and vitamin K, and (3) tertiary metabolic support and detoxification systems encompassing thioredoxin, AKR1C enzymes, SOD‐catalase, and NADPH regeneration. The regulation of these defenses by master signaling hubs including NRF2, AMPK‐mTOR, ATF4, STAT3, Wnt/beta‐catenin, p53, and ncRNAs is evaluated, alongside oncogenic metabolic adaptations creating exploitable vulnerabilities in high‐plasticity states including epithelial to mesenchymal transition, cancer stem cells, hypoxic, matrix‐detached, and chemoresistant cells. Tumor microenvironment crosstalk among cancer‐associated fibroblasts and immune effectors, including CD8 + T cells, natural killer cells, macrophages, and myeloid‐derived suppressor cells, and therapeutic strategies spanning pharmacological and nanomaterial‐based approaches are further examined. Collectively, this synthesis furnishes a mechanistic framework for precision exploitation of ferroptosis across oncological contexts.
- Open Access
- 13 June 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1) , 799
Author Correction: HLA polymorphisms shape divergent outcomes of Toxoplasma and Plasmodium infection in Eastern Indian HbE/β-thalassemia cohort
- 13 June 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1) , 799
Open AccessAuthor Correction: HLA polymorphisms shape divergent outcomes of Toxoplasma and Plasmodium infection in Eastern Indian HbE/β-thalassemia cohort
- Open Access
- 25 May 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1) , 690
HLA polymorphisms shape divergent outcomes of Toxoplasma and Plasmodium infection in Eastern Indian HbE/β-thalassemia cohort
Genetic disorders such as HbE/β-thalassemia (HBT), though deleterious, may undergo positive selection in regions of high parasitic-endemicity, shaping infection outcomes. By integrating NGS and Sanger sequencing from 61 HBT patients and 50 healthy controls, with imaging-based ex-vivo infection-assays and biochemical analysis, we demonstrate, that individuals carrying the HLA-A*33 allele in an Eastern Indian HBT-cohort show significant protection against Toxoplasma gondii infection compared to A*33-negative counterparts. Importantly, this protective phenotype was independent of transfusion frequency. Infection assays in peripheral blood mononuclear cells (PBMCs) confirmed that while parasite entry was unaffected, intracellular replication was markedly restricted in A*33-positive PBMCs, correlating with enhanced CD8⁺ IFN-γ⁺ responses relative to susceptible HLA genotypes. SPR binding studies using recombinant A*33 and Toxoplasma-derived antigenic-peptide SAG2C, revealed that elevated IFN-γ production is linked higher binding affinity of A*33 with SAG2C, leading to improved antigen presentation. Interestingly, A*33 did not confer protection against Plasmodium falciparum, a closely related apicomplexan parasite sharing common ancestry and intracellular lifestyle with Toxoplasma. Instead, NGS-based HLA profiling in this HBT patient-cohort identified a potential negative association between HLA-C*07 and Plasmodium-infection, validated through infection studies in HLA-null K562 cell lines expressing C*07 or A*33. C*07 exhibited strong binding affinity to the Plasmodium-specific MSP3 peptide but not to SAG2C, indicating pathogen-specific antigen recognition with minimal cross-reactivity. These findings highlight the functional interplay between host HLA diversity and apicomplexan antigen specificity, suggesting that selective immune advantages may contribute to the persistence of otherwise deleterious HBT genotypes in Apicomplexan-endemic populations The alternative text for this image may have been generated using AI.
- 25 May 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1) , 690
Open AccessHLA polymorphisms shape divergent outcomes of Toxoplasma and Plasmodium infection in Eastern Indian HbE/β-thalassemia cohort
Genetic disorders such as HbE/β-thalassemia (HBT), though deleterious, may undergo positive selection in regions of high parasitic-endemicity, shaping infection outcomes. By integrating NGS and Sanger sequencing from 61 HBT patients and 50 healthy controls, with imaging-based ex-vivo infection-assays and biochemical analysis, we demonstrate, that individuals carrying the HLA-A*33 allele in an Eastern Indian HBT-cohort show significant protection against Toxoplasma gondii infection compared to A*33-negative counterparts. Importantly, this protective phenotype was independent of transfusion frequency. Infection assays in peripheral blood mononuclear cells (PBMCs) confirmed that while parasite entry was unaffected, intracellular replication was markedly restricted in A*33-positive PBMCs, correlating with enhanced CD8⁺ IFN-γ⁺ responses relative to susceptible HLA genotypes. SPR binding studies using recombinant A*33 and Toxoplasma-derived antigenic-peptide SAG2C, revealed that elevated IFN-γ production is linked higher binding affinity of A*33 with SAG2C, leading to improved antigen presentation. Interestingly, A*33 did not confer protection against Plasmodium falciparum, a closely related apicomplexan parasite sharing common ancestry and intracellular lifestyle with Toxoplasma. Instead, NGS-based HLA profiling in this HBT patient-cohort identified a potential negative association between HLA-C*07 and Plasmodium-infection, validated through infection studies in HLA-null K562 cell lines expressing C*07 or A*33. C*07 exhibited strong binding affinity to the Plasmodium-specific MSP3 peptide but not to SAG2C, indicating pathogen-specific antigen recognition with minimal cross-reactivity. These findings highlight the functional interplay between host HLA diversity and apicomplexan antigen specificity, suggesting that selective immune advantages may contribute to the persistence of otherwise deleterious HBT genotypes in Apicomplexan-endemic populations The alternative text for this image may have been generated using AI.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
Nature-inspired design of carbon dots for multifunctional applications in 6-mercaptopurine sensing, bioimaging, and bacterial growth promotion
Natural in-built calcium-doped carbon dots as a PL enhancement mode sensing probe.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
Nature-inspired design of carbon dots for multifunctional applications in 6-mercaptopurine sensing, bioimaging, and bacterial growth promotion
Natural in-built calcium-doped carbon dots as a PL enhancement mode sensing probe.
- Open Access
- 22 December 2025
- Published by Elsevier in STAR Protocols
- Vol. 7 (1) , 104285
FibroPrep protocol for rapid enzyme-free isolation of primary dermal fibroblasts from adult mouse skin for biological assays
- 22 December 2025
- Published by Elsevier in STAR Protocols
- Vol. 7 (1) , 104285
Open AccessFibroPrep protocol for rapid enzyme-free isolation of primary dermal fibroblasts from adult mouse skin for biological assays
- Open Access
Leishmania donovani GP63 paralogues cooperatively orchestrate visceral infection and persistence
Highly plastic genome of Leishmania is thought to underlie its remarkable ability to adapt to diverse host microenvironments, yet how this plasticity translates into dermal versus visceral persistence remains unclear. GP63, a zinc metalloprotease, is a well-established determinant of promastigote infectivity, particularly in cutaneous leishmaniasis. Despite this, its role in amastigote stage and in visceral disease caused by Leishmania donovani remains undefined. Here, using an integrated approach combining phylogenetics, CRISPR-mediated genome editing, and biochemical analyses, we demonstrate that GP63 paralogues in L. donovani have undergone independent evolutionary diversification to support visceral infection. While GP63-paralogues encoded on chromosome 10, previously implicated in cutaneous manifestation caused by L. major , were found severely truncated and dispensable in L. donovani, two distinct GP63-paralogues encoded on chromosome 28 and 31 were found ‘essential’ to establish visceral infection. LdGP63_31 facilitates promastigote attachment to macrophages by promoting lipid raft engagement and complement inactivation, thereby enabling host entry and subsequent amastigote differentiation. LdGP63_28 is essential for intracellular amastigote survival by suppressing host inflammatory pyroptosis. Structural and enzymatic analyses revealed preferential host localization and substrate specificities, possibly resulting from distinct amino acid substitution within conserved motifs of these proteases, indicating independent evolutionary adaptations. Importantly, loss of the LdGP63_28 more severely impaired amastigote reinfection than loss of its counterpart LdGP63_31. Together, these findings reveal coordinated functional specialization of GP63-paralogues ensuring visceral adaptation.
Open AccessLeishmania donovani GP63 paralogues cooperatively orchestrate visceral infection and persistence
Highly plastic genome of Leishmania is thought to underlie its remarkable ability to adapt to diverse host microenvironments, yet how this plasticity translates into dermal versus visceral persistence remains unclear. GP63, a zinc metalloprotease, is a well-established determinant of promastigote infectivity, particularly in cutaneous leishmaniasis. Despite this, its role in amastigote stage and in visceral disease caused by Leishmania donovani remains undefined. Here, using an integrated approach combining phylogenetics, CRISPR-mediated genome editing, and biochemical analyses, we demonstrate that GP63 paralogues in L. donovani have undergone independent evolutionary diversification to support visceral infection. While GP63-paralogues encoded on chromosome 10, previously implicated in cutaneous manifestation caused by L. major , were found severely truncated and dispensable in L. donovani, two distinct GP63-paralogues encoded on chromosome 28 and 31 were found ‘essential’ to establish visceral infection. LdGP63_31 facilitates promastigote attachment to macrophages by promoting lipid raft engagement and complement inactivation, thereby enabling host entry and subsequent amastigote differentiation. LdGP63_28 is essential for intracellular amastigote survival by suppressing host inflammatory pyroptosis. Structural and enzymatic analyses revealed preferential host localization and substrate specificities, possibly resulting from distinct amino acid substitution within conserved motifs of these proteases, indicating independent evolutionary adaptations. Importantly, loss of the LdGP63_28 more severely impaired amastigote reinfection than loss of its counterpart LdGP63_31. Together, these findings reveal coordinated functional specialization of GP63-paralogues ensuring visceral adaptation.
- Open Access
Distinct polymorphisms in HLA-class-I molecules of HbE/B-thalassemia cohort in Eastern India influences their vulnerability to Apicomplexan infections
Although genetic disorders like HbE/β-thalassemia-(HBT) are associated with detrimental health outcomes, they may be subject to positive-selection in endemic regions of parasitic infections. In sub-Saharan-Africa, individuals with HBT, dependent on regular blood-transfusions have been observed to exhibit protection against malaria, while remaining susceptible to toxoplasmosis. This observation suggests, hematological genetic-disorders may significantly influence pathogenesis of Apicomplexan infections. In HBT-patients from Eastern-India, protection against toxoplasmosis was identified in individuals carrying Human-Leukocyte-Antigen-A*33-(HLA-A*33) allele. This protective effect was found to be conserved in peripheral-blood-mononuclear-cells-(PBMCs) obtained from both HBT-patients and healthy-controls. While parasite-entry into PBMCs was permitted, intracellular proliferation was restricted, which was linked to significantly enhanced CD8⁺-IFN-γ⁺ response in A*33-positive-cells relative to susceptible-genotypes. The elevated IFN-γ production was attributed to increased binding-affinity of A*33 with Toxoplasma -derived-peptides like SAG2C, leading to improved antigen-presentation. Interestingly, no protective role of A*33 was observed against Plasmodium , indicating a pathogen-specific interaction between HLA-alleles and Apicomplexan-derived-antigens. Further next-generation-sequencing of class-I and-II HLA-loci in HBT-patients revealed a potential association between HLA-C*07 and protection against Plasmodium infection. These findings provide mechanistic insights into how host genetic-factors may influence susceptibility to Apicomplexan infections and suggest that such interactions could contribute to evolutionary persistence of deleterious HBT-mutations in regions where these infections are co-prevalent. Graphical Graphical Schematic Representation of allele-pathogen dynamics explored in this study, highlighting the selective fitness advantage conferred by specific HLA variants in the context of Toxoplasma and Plasmodium infection.
Open AccessDistinct polymorphisms in HLA-class-I molecules of HbE/B-thalassemia cohort in Eastern India influences their vulnerability to Apicomplexan infections
Although genetic disorders like HbE/β-thalassemia-(HBT) are associated with detrimental health outcomes, they may be subject to positive-selection in endemic regions of parasitic infections. In sub-Saharan-Africa, individuals with HBT, dependent on regular blood-transfusions have been observed to exhibit protection against malaria, while remaining susceptible to toxoplasmosis. This observation suggests, hematological genetic-disorders may significantly influence pathogenesis of Apicomplexan infections. In HBT-patients from Eastern-India, protection against toxoplasmosis was identified in individuals carrying Human-Leukocyte-Antigen-A*33-(HLA-A*33) allele. This protective effect was found to be conserved in peripheral-blood-mononuclear-cells-(PBMCs) obtained from both HBT-patients and healthy-controls. While parasite-entry into PBMCs was permitted, intracellular proliferation was restricted, which was linked to significantly enhanced CD8⁺-IFN-γ⁺ response in A*33-positive-cells relative to susceptible-genotypes. The elevated IFN-γ production was attributed to increased binding-affinity of A*33 with Toxoplasma -derived-peptides like SAG2C, leading to improved antigen-presentation. Interestingly, no protective role of A*33 was observed against Plasmodium , indicating a pathogen-specific interaction between HLA-alleles and Apicomplexan-derived-antigens. Further next-generation-sequencing of class-I and-II HLA-loci in HBT-patients revealed a potential association between HLA-C*07 and protection against Plasmodium infection. These findings provide mechanistic insights into how host genetic-factors may influence susceptibility to Apicomplexan infections and suggest that such interactions could contribute to evolutionary persistence of deleterious HBT-mutations in regions where these infections are co-prevalent. Graphical Graphical Schematic Representation of allele-pathogen dynamics explored in this study, highlighting the selective fitness advantage conferred by specific HLA variants in the context of Toxoplasma and Plasmodium infection.
- Open Access
- 12 August 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Correction: Scrutinized lipid utilization disrupts Amphotericin-B responsiveness in clinical isolates of Leishmania donovani
Pradhan S, Dhar D, Manna D, Chakraborty S, Bhattacharyya A, Chauhan K, Mukherjee R, Sen A, Pandey K, Das S, Mukherjee B. 2025. Scrutinized lipid utilization disrupts Amphotericin-B responsiveness in clinical isolates of Leishmania donovani. eLife 14:RP102857. doi: 10.7554/eLife.102857.
- 12 August 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Open AccessCorrection: Scrutinized lipid utilization disrupts Amphotericin-B responsiveness in clinical isolates of Leishmania donovani
Pradhan S, Dhar D, Manna D, Chakraborty S, Bhattacharyya A, Chauhan K, Mukherjee R, Sen A, Pandey K, Das S, Mukherjee B. 2025. Scrutinized lipid utilization disrupts Amphotericin-B responsiveness in clinical isolates of Leishmania donovani. eLife 14:RP102857. doi: 10.7554/eLife.102857.
- Open Access
- 1 July 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (2) , e001308
Community-based intervention to address antibiotic resistance: protocol for an embedded mixed-methods intervention trial
Introduction: Antibiotic resistance is a global threat that occurs naturally; however, the misuse and overuse of antibiotics in humans and animals are accelerating the process, necessitating ‘one health’ approach to mitigate the situation. Considering the ‘one health’ approach in the proposed study, it is the novel concept for implementation in the Indian context. The proposed study would generate evidence on the burden of antibiotic resistance, awareness and practices of proper antibiotic consumption among community members in West Bengal. The intervention package proposed in this study will be a novel intervention, which can be integrated with the existing healthcare delivery system as well. Methods and analysis: The proposed study will be an embedded mixed-methods interventional community-based study to be conducted in greater Kolkata region and West Medinipur district among adults (≥18 years) who will give consent for participation, and preferably residing in a particular area for more than 10 years. Intervention in the form of a behavioural intervention package, targeting awareness, perceived severity and perceived susceptibility regarding the issue of antibiotic resistance will be developed and implemented through randomisation of clusters. Data collection in the form of survey, observation, in-depth interview, collection of human, animal and environment samples will be carried out. Ethics and dissemination: The ethical clearance has been obtained from the Institutional ethics committee, Indian Institute of Technology, Kharagpur. The findings of this project will be communicated to the State Government Health Officials. Trial registration number: CTRI/2023/02/050054.
- 1 July 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (2) , e001308
Open AccessCommunity-based intervention to address antibiotic resistance: protocol for an embedded mixed-methods intervention trial
Introduction: Antibiotic resistance is a global threat that occurs naturally; however, the misuse and overuse of antibiotics in humans and animals are accelerating the process, necessitating ‘one health’ approach to mitigate the situation. Considering the ‘one health’ approach in the proposed study, it is the novel concept for implementation in the Indian context. The proposed study would generate evidence on the burden of antibiotic resistance, awareness and practices of proper antibiotic consumption among community members in West Bengal. The intervention package proposed in this study will be a novel intervention, which can be integrated with the existing healthcare delivery system as well. Methods and analysis: The proposed study will be an embedded mixed-methods interventional community-based study to be conducted in greater Kolkata region and West Medinipur district among adults (≥18 years) who will give consent for participation, and preferably residing in a particular area for more than 10 years. Intervention in the form of a behavioural intervention package, targeting awareness, perceived severity and perceived susceptibility regarding the issue of antibiotic resistance will be developed and implemented through randomisation of clusters. Data collection in the form of survey, observation, in-depth interview, collection of human, animal and environment samples will be carried out. Ethics and dissemination: The ethical clearance has been obtained from the Institutional ethics committee, Indian Institute of Technology, Kharagpur. The findings of this project will be communicated to the State Government Health Officials. Trial registration number: CTRI/2023/02/050054.